Servier and Day One Biopharmaceuticals Inc. jointly announced an acquisition agreement, which will significantly enhance Servier's product pipeline in the field of rare tumor treatments.
Show original
Through this strategic acquisition, Servier aims to accelerate the research and commercialization of its rare oncology drugs, providing more advanced treatment options for patients worldwide.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Contract whale pension-usdt.eth begins reducing its bitcoin short positions
Chaincatcher•2026/03/07 07:14
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$67,822.63
-4.69%
Ethereum
ETH
$1,978.78
-5.17%
Tether USDt
USDT
$0.9999
-0.00%
BNB
BNB
$627.27
-3.07%
XRP
XRP
$1.36
-3.01%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$84.19
-5.08%
TRON
TRX
$0.2836
-0.93%
Dogecoin
DOGE
$0.09058
-3.73%
Cardano
ADA
$0.2581
-4.88%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now